Global Injectable Fillers Market Size, Share and Trends Analysis Report, By Type (Hyaluronic Acid (HA), Calcium Hydroxylapatite, Polymethyl-Methacrylate Microspheres (PMMA), and Others), By Application (Facelift, Facial Line Correction, Lip Enhancement, and Others), Forecast (2022-2028)

The global injectable fillers market is anticipated to grow at a significant CAGR 9% during the forecast period (2022-2028). The major factor expected to drive the market is the rising demand for hyaluronic acid products in aesthetics and dermatology for volume restoration and wrinkle augmentation therapies. Furthermore, the market is emerging owing to factors such as low level of pain, less scarring, and the requirement of smaller cuts. Moreover, an increase in the aging population, and benefits associated with the injectable fillers such as rejuvenation of the skin, and restoration of the lost collagen from the body are primarily supporting to drive the growth of the market.

In addition, several companies engaged in manufacturing facial injectables have invested considerably in R&D initiatives which have led to the development of a considerable number of products with significantly improved aesthetic outcomes. Such R&D and product launches are also expected to contribute to the growth of the market. Furthermore, growing awareness of cosmetic anti-aging processes and the rise in the prevalence of minimally invasive surgeries is expected to boost the market growth during the forecast period.

Some major players in the market include Allergan plc (AbbVie Inc.), Galderma SA, and Revance Therapeutics, Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2021, Galderma SA announced the re-launch of Sculptra (injectable Poly-L-lactic acid) in Europe with an updated administration protocol.

Additionally, in August 2020, Revance Therapeutics, Inc. announced the launch of RHA Dermal Filler Line the first and only Food and Drug Administration (FDA) approved dermal fillers for correction of dynamic facial wrinkles and folds in the US. Furthermore, in January 2021, Merz Pharma GmbH & Co.KGaA and Candela corp. launched the commercial collaboration to create a broad medical aesthetics portfolio. In September 2019, Allergan plc. announced about receiving approval from the US Food and Drug Administration (FDA) for Juvéderm VOLUMA XC with TSK STERiGLIDE cannula for augmentation of cheeks in people aged above 21 years. The filler is intended to correct age-related volume insufficiency in the mid-face.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

• Competitive Landscape- Allergan plc (AbbVie Inc.), Galderma SA, and Revance Therapeutics, Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Injectable Fillers Market Report by Segment

By Type

• Hyaluronic Acid (HA)
• Calcium Hydroxylapatite
• Polymethyl-Methacrylate Microspheres (PMMA)
• Others

By Application

• Facelift
• Facial Line Correction
• Lip Enhancement
• Others

Global Injectable Fillers Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa